Viewing Study NCT04891302


Ignite Creation Date: 2025-12-25 @ 3:56 AM
Ignite Modification Date: 2026-01-28 @ 6:50 PM
Study NCT ID: NCT04891302
Status: COMPLETED
Last Update Posted: 2022-07-22
First Post: 2021-05-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Proof of Concept Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Mild and Moderate COVID-19
Sponsor: Bukwang Pharmaceutical
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None COVID-19 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Clevudine View